Codiak BioSciences, Inc. Common Stock
CDAK
CDAK was delisted on the 4th of April, 2023.
47 hedge funds and large institutions have $188M invested in Codiak BioSciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 8 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
0% more funds holding
Funds holding: 47 → 47 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
39% less capital invested
Capital invested by funds: $310M → $188M (-$122M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$18.4M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$11.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$9.29M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$14.5M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$3.68M |
| 3 |
MCM
Moore Capital Management
New York
|
-$676K |
| 4 |
CCM
CAAS Capital Management
New York
|
-$485K |
| 5 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$302K |
CDAK Hedge Fund Activity: Q1 2021 in Review
47 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Codiak BioSciences, Inc. Common Stock (CDAK) for Q1 2021, worth a combined $188M — down 39% from $310M a quarter earlier.
Fund positioning in CDAK was balanced in Q1 2021: 8 funds opened new positions, 8 closed out, 16 added to existing stakes and 11 trimmed.
The largest buyer was University of Texas/Texas AM Investment Management Co (UTIMCO), opening a new position worth an estimated $18.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $14.5M sold.
- 47 institutional investors held Codiak BioSciences, Inc. Common Stock (CDAK) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $188M of Codiak BioSciences, Inc. Common Stock stock for Q1 2021, down 39% quarter-over-quarter.
- 8 funds opened new Codiak BioSciences, Inc. Common Stock positions in Q1 2021 and 8 closed out, a net change of 0 holders.
- The largest Codiak BioSciences, Inc. Common Stock buyer in Q1 2021 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $18.4M added.
- The largest Codiak BioSciences, Inc. Common Stock seller in Q1 2021 was Deerfield Management, an estimated $14.5M sold.
Based on aggregated 13F filings for Q1 2021.